Boston Scientific Settles With SEC On 1997/98 Japan Sales Irregularities
This article was originally published in The Gray Sheet
Executive Summary
A settlement reached between Boston Scientific and the Securities and Exchange Commission in connection with improperly recorded sales by the company's Japanese operation does not include a fine.